Allergan Inc. halted a bruising seven-month takeover fight with its unwanted suitor, Valeant Pharmaceuticals, by agreeing on Monday to sell itself to Dublin, Ireland-based Actavis Plc for $65.7 billion in a friendly cash and stock deal. The...
By BERNARD J. WOLFSON, Orange County Register: Business
Mon, 11/17/2014 - 7:01pm
Allergan Inc. halted a bruising seven-month takeover fight with its unwanted suitor, Valeant Pharmaceuticals, by agreeing on Monday to sell itself to Dublin, Ireland-based Actavis Plc for $65.7 billion in a friendly cash and stock deal. The...